Journal of Psychology and Cognition

All submissions of the EM system will be redirected to Online Manuscript Submission System. Authors are requested to submit articles directly to Online Manuscript Submission System of respective journal.
Reach Us +44-7482878454

Barriers to Naloxone access even though it is legal without prescription it still elusive

2nd International Conference on Addiction Research and Therapy
May 13-14, 2019 | Prague, Czech Republic

Ella Bannister

Alabama Harm Reduction Coalition, USA

Posters & Accepted Abstracts : J Psychol Cognition

Abstract:

Naloxone (narcan) is an opioid antagonist that can reverse an opioid overdose. Naloxone access varies from state-tostate (government-to-government). Naloxone prescriptions dispensed from retail pharmacies increase nearly 12-fold between the fourth quarter of 2013 and the second quarter of 2015. Many states have passed laws to broaden the availability of been Lots on for users, friends, family, and other potential witnesses of overdose. However, some states even though they have passed naloxone laws those laws remain extremely restrictive / prohibitive when it comes to distributing to lay individuals within the communities. Some states allow no access to Community-Based Organizations that can secure funding to bolster the amount of Narcan available for circulation to community members. Also, cost remains prohibitively expensive. Managed healthcare insurers only allow for one dose coverage per month at the $40 copay, thereafter; the consumer cost Rises to $350 per dose on the second dose and even higher after that dose. It is also worth noting that insurance coverage will only allow the co-pay process for the individual and active use not the other potential by standards. Community-Based Organizations access to special pricing to lower this cost exponentially and then turn save lives in all socioeconomic groups. Let's discuss barriers to want to walk home from policy to access. As well as, how we can be part of the solution.

Biography:

E-mail:

[email protected]

PDF HTML